Concepedia

Mahendran Botlagunta

MB

20

Publications

984

Citations

15

H-Index

2006

Active since

Affiliations

Koneru Lakshmaiah Education Foundation(Current)

Johns Hopkins University

Johns Hopkins Medicine

Institute of Life Sciences

Cancer Hospital and Research Institute

Mahendran Botlagunta is an author at Koneru Lakshmaiah Education Foundation specializing in medicine, natural sciences, and tumor biology.

ORCID

Top concepts

Publications per year

2006–2023

20

Publications

20

Oncogenic role of DDX3 in breast cancer biogenesis

Mahendran Botlagunta, Farhad Vesuna, Yelena Mironchik et al. · Oncogene · 2008 · 219 citations · Full text

, , +5

Classification and diagnostic prediction of breast cancer metastasis on clinical data using machine learning algorithms

Mahendran Botlagunta, Madhavi Devi Botlagunta, Madhu Bala Myneni et al. · Scientific Reports · 2023 · 178 citations · Full text

DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG

Omprakash Shriwas, Manashi Priyadarshini, Sabindra K. Samal et al. · APOPTOSIS · 2020 · 142 citations

, , +8

Ketorolac salt is a newly discovered DDX3 inhibitor to treat oral cancer

Sabindra K. Samal, Samapika Routray, Ganesh Kumar Veeramachaneni et al. · Scientific Reports · 2015 · 74 citations · Full text

NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3

Min Xie, Farhad Vesuna, Mahendran Botlagunta et al. · Oncotarget · 2015 · 54 citations · Full text

Rows per page

1–5 of 20